SCHEMBL7571074

SCHEMBL7571074

CC(=O)Oc1ccc(-c2coc3cc(O[Si](C)(C)C(C)(C)C)cc(OC(C)=O)c3c2=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.72
SMN1; SMN2 Q16637 7/20 0.72
HSD17B10 Q99714 6/20 0.72
CYP3A4 P08684 6/20 0.72
TP53 P04637 3/20 0.72
ALDH1A1 P00352 7/20 0.53
NPC1 O15118 5/20 0.53
RAB9A P51151 4/20 0.53
MAPT P10636 6/20 0.50
HPGD P15428 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
RECQL P46063 2/20 0.48
ALOX15 P16050 1/20 0.48
APEX1 P27695 1/20 0.48
BLM P54132 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
NFKB1 P19838 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565177 0.90 SMN1; SMN2 (0.60) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL2072196 0.89 KDM4E (0.89) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL26145311 0.84 KDM4E (1.00) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL29936595 0.84 KDM4E (1.00) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL7564891 0.82 SMN1; SMN2 (0.73) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL7567985 0.80 NPC1 (0.68) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL7567000 0.78 ALDH2 (0.72) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL3957582 0.78 SMN1; SMN2 (0.69) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL31236167 0.77 SMN1; SMN2 (0.69) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53
SCHEMBL10001911 0.77 KDM4E (0.68) KDM4ESMN1; SMN2HSD17B10CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002081491-A2 NEW GENISTEIN DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM INSTYTUT FARMACEUTYCZNY (PL) 2002-10-17 WO disclosed